يعرض 1 - 20 نتائج من 71 نتيجة بحث عن '"A. O. Guz'"', وقت الاستعلام: 0.53s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal

    المساهمون: The work was performed without external funding, Работа выполнена без спонсорской поддержки

    المصدر: Head and Neck Tumors (HNT); Том 13, № 4 (2023); 10-18 ; Опухоли головы и шеи; Том 13, № 4 (2023); 10-18 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2023-13-4

    وصف الملف: application/pdf

    Relation: https://ogsh.abvpress.ru/jour/article/view/932/602; Состояние онкологической помощи населению России в 2020 году. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2021. 239 с.; Zanoni D.K., Montero P.H., Migliacci J.C. et al. Survival outcomes after treatment of cancer of the oral cavity (1985–2015). Oral Oncol 2019;90:115–21. DOI:10.1016/j.oraloncology.2019.02.001; National Comprehensive Cancer Network. Head and neck cancers. Version 3. 2021. Available at: https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.; Клинические рекомендации «Злокачественные новообразования полости рта». 2020 г. Доступно по: https://oncology-association.ru/wp-content/uploads/2020/09/zno_polosti_rta.pdf.; Jang J.Y., Choi N., Jeong H.S. Surgical extent for oral cancer: emphasis on a cut-off value for the resection margin status: a narrative literature review. Cancers (Basel) 2022;14(22):5702. DOI:10.3390/cancers14225702; Anderson C.R., Sisson K., Moncrieff M. A meta-analysis of margin size and local recurrence in oral squamous cell carcinoma. Oral Oncol 2015;51(5):464–9. DOI:10.1016/j.oraloncology.2015.01.015; Johnson R.E., Sigman J.D., Funk G.F. et al. Quantification of surgical margin shrinkage in the oral cavity. Head Neck 1997;19(4):281–6. DOI:10.1002/(sici)1097–0347(199707)19:43.0.co;2-x; Mistry R.C., Qureshi S.S., Kumaran C. Post-resection mucosal margin shrinkage in oral cancer: quantification and significance. J Surg Oncol 2005;91(2):131–3. DOI:10.1002/jso.20285; Luryi A.L., Chen M.M., Mehra S. et al. Positive surgical margins in early stage oral cavity cancer: an analysis of 20,602 cases. Otolaryngol Head Neck Surg 2014;151(6):984–90. DOI:10.1177/0194599814551718; Schwam Z.G., Judson B.L. Improved prognosis for patients with oral cavity squamous cell carcinoma: analysis of the National Cancer Database 1998–2006. Oral Oncol 2016;52:45–51. DOI:10.1016/j.oraloncology.2015.10.012; Garg A., Mair M., Singhavi H., Bhati M. et al. Adequacy of surgical margins in oral cancer patients with respect to various types of reconstruction. South Asian J Cancer 2020;9(1):34–7. DOI:10.4103/sajc.sajc_366_18; Sutton D.N., Brown J.S., Rogers S.N. et al. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2003;32(1):30–4. DOI:10.1054/ijom.2002.0313; Buchakjian M.R., Ginader T., Tasche K.K. et al. Independent predictors of prognosis based on oral cavity squamous cell carcinoma surgical margins. Otolaryngol Head Neck Surg 2018;159(4):675–82. DOI:10.1177/0194599818773070; Fowler J., Campanile Y., Warner A. et al. Surgical margins of the oral cavity: is 5 mm really necessary? J Otolaryngol Head Neck Surg 2022;51(1):38. DOI:10.1186/s40463-022-00584-8; Ellis O.G., David M.C., Park D.J., Batstone M.D. High-volume surgeons deliver larger surgical margins in oral cavity cancer. J Oral Maxillofac Surg 2016;74(7):1466–72. DOI:10.1016/j.joms.2016.01.026; Hanasono M.M., Friel M.T., Klem C. et al. Impact of reconstructive microsurgery in patients with advanced oral cavity cancers. Head Neck 2009;31(10):1289–96. DOI:10.1002/hed.21100; Liao C.T., Wen Y.W., Lee S.R. et al. Сlinical outcomes of taiwanese patients with resected oral cavity squamous cell carcinoma who underwent reconstruction with free versus local flaps. Ann Surg Oncol 2022;29(2):1130–40. DOI:10.1245/s10434-021-10524-x; Hsieh T.Y., Chang K.P., Lee S.S. et al. Free flap reconstruction in patients with advanced oral squamous cell carcinoma: analysis of patient survival and cancer recurrence. Microsurgery 2012;32(8):598–604. DOI:10.1002/micr.22009; Forner D., Phillips T., Rigby M. et al. Submental island flap reconstruction reduces cost in oral cancer reconstruction compared to radial forearm free flap reconstruction: a case series and cost analysis. J Otolaryngol Head Neck Surg 2016;45:11. DOI:10.1186/s40463-016-0124-8; Kubik M.W., Sridharan S., Varvares M.A. et al. Intraoperative margin assessment in head and neck cancer: a case of misuse and abuse? Head Neck Pathol 2020;14(2):291–302. DOI:10.1007/s12105-019-01121-2; Bajwa M.S., Houghton D., Java K. et al. The relevance of surgical margins in clinically early oral squamous cell carcinoma. Oral Oncol 2020;110:104913. DOI:10.1016/j.oraloncology.2020.104913; Zanoni D.K., Migliacci J.C., Xu B. et al. A proposal to redefine close surgical margins in squamous cell carcinoma of the oral tongue. JAMA Otolaryngol Head Neck Surg 2017;143(6):555–60. DOI:10.1001/jamaoto.2016.4238; https://ogsh.abvpress.ru/jour/article/view/932

  4. 4
    Academic Journal

    المساهمون: This publication has been prepared with the financial support of Eisai. The authors are solely responsible for the content of the publication and editorial decisions, Данная публикация подготовлена при финансовой поддержке компании «Эйсай». Авторы несут полную ответственность за содержание публикации и редакционные решения

    المصدر: Head and Neck Tumors (HNT); Том 14, № 2 (2024); 98-107 ; Опухоли головы и шеи; Том 14, № 2 (2024); 98-107 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2024-14-2

    وصف الملف: application/pdf

    Relation: https://ogsh.abvpress.ru/jour/article/view/986/635; Румянцев П.О., Фомин Д.К., Румянцева У.В. Критерии радиойодрезистентности высокодифференцированного рака щитовидной железы к терапии радиоактивным йодом. Опухоли головы и шеи 2014;(3):4–9. DOI:10.17650/2222-1468-2014-0-3-4-9; Durante C., Haddy N., Baudin E. et al. Long-term outcome of 444 patients with distant metastases from papillary andfollicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 2006;91(8):2892–9. DOI:10.1210/jc.2005-2838; Eustatia-Rutten C.F., Corssmit E.P., Biermasz N.R. et al. Survival and death causes in differentiated thyroid carcinoma. J Clin Endocrinol Metab 2006;91(1):313–9. DOI:10.1210/jc.2005-1322; Шуринов А.Ю., Бородавина Е.В., Крылов В.В. и др. Методические рекомендации по проведению радиойодтерапии при дифференцированном раке щитовидной железы и посттерапевтическому контролю. Опухоли головы и шеи 2024;14(1): 83–95. DOI:10.17650/2222-1468-2024-14-1-83-95; Чойнзонов Е.Л., Решетов И.В., Иванов С.А. и др. Проект клинических рекомендаций по диагностике и лечению дифференцированного рака щитовидной железы у взрослых пациентов. Эндокринная хирургия 2022;16(2):5–29. DOI:10.14341/serg12792; Haugen B., Alexander E., Bible Keith C. et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26(1):1–133. DOI:10.1089/thy.2015.0020; Шуринов А.Ю., Бородавина Е.В. Динамический контроль после радиойодабляции при дифференцированном раке щитовидной железы: взгляд радиолога. Опухоли головы и шеи 2023;13(1):91–101. DOI:10.17650/2222-1468-2023-13-1-91-101; Biondi B., Cooper D.S. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid 2010;20(2):135–46. DOI:10.1089/thy.2009.0311; Eisenhauer E.A., Therasse P., Bogaerts J. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45(2):228–47. DOI:10.1016/j.ejca.2008.10.026; Болотина Л.В., Владимирова Л.Ю., Деньгина Н.В. и др. Практические рекомендации по лекарственному лечению опухолей головы и шеи. Практические рекомендации RUSSCO, часть 1. Злокачественные опухоли 2023;13:100–19.; Schlumberger M., Brose M., Elisei R. et al. Definition and management of radioactive iodine-refractory differentiated thyroid cancer. Lancet Diabetes Endocrinol 2014;2(5):356–8. DOI:10.1016/S2213-8587(13)70215-8; Berdelou A., Lamartina L., Klain M. et al. Treatment of refractory thyroid cancer. Endocr Relat Cancer 2018;25(4):R209–23. DOI:10.1530/ERC-17-0542; Tuttle R.M., Brose M.S., Grande E. et al. Novel concepts for initiating multitargeted kinase inhibitors in radioactive iodine refractory differentiated thyroid cancer. Best Pract Res Clin Endocrinol Metab 2017;31(3):295–305.; Castagna M.G., Maino F., Cipri C. et al. Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients. Eur J Endocrinol 2011;165(3):441–6. DOI:10.1530/EJE-11-0466; Gruber J.J., Colevas A.D. Differentiated thyroid cancer: focus on emerging treatments for radioactive iodine-refractory patients. Oncologist 2015;20(2):113–26. DOI:10.1634/theoncologist.2014-0313; Durante C., Attard M., Torlontano M. et al. Identification and optimal postsurgical follow-up of patients with very low-risk papillary thyroid microcarcinomas. J Clin Endocrinol Metab 2010;95(11):4882–8. DOI:10.1210/jc.2010-0762; Grani G., Lamartina L., Cantisani V. et al. Interobserver agreement of various thyroid imaging reporting and data systems. Endocr Connect 2018;7(1):1–7. DOI:10.1530/EC-17-0336; Lamartina L., Grani G., Biffoni M. et al. Risk stratification of neck lesions detected sonographically during the follow-up of differentiated thyroid cancer. J Clin Endocrinol Metab 2016;101(8):3036–44. DOI:10.1210/jc.2016-1440; Leenhardt L., Erdogan M.F., Hegedus L. et al. 2013 European Thyroid Association Guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyroid J 2013;2(3):147–59. DOI:10.1159/000354537; Sgouros G., Kolbert K.S., Sheikh A. et al. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-Dimensional-Internal Dosimetry (3D-ID) software. J Nucl Med 2004;45(8):1366–72.; Robbins R.J., Wan Q., Grewal R.K. et al. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxyD-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 2006. DOI:10.1210/jc.2005-1534; Leboulleux S., El Bez I., Borget I. et al. Post-radioiodine treatment whole body scan in the era of fluorodesoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels. Thyroid 2012. DOI:10.1089/thy.2012-0081; NCCN Clinical Practice Guidelines in Oncology Thyroid Carcinoma. Version 4.2023. August 16, 2023. NCCN. Published online 2023. DOI:10.1001/jamaoncol.2018.2706; Taylor M.H., Takahashi S., Capdevila J. et al. Correlation of performance status and neutrophil-lymphocyte ratio with efficacy in radioiodine-refractory differentiated thyroid cancer treated with lenvatinib. Thyroid 2021;31(8):1226–34. DOI:10.1089/thy.2020.0779; Tahara M., Kiyota N., Hoff A.O. et al. Impact of lung metastases on overall survival in the phase 3 SELECT study of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer. Eur J Cancer 2021;147:51–7. DOI:10.1016/j.ejca.2020.12.032; Brose M.S., Panaseykin Y., Konda B. et al. A randomized study of lenvatinib 18 mg vs 24 mg in patients with radioiodine-refractory differentiated thyroid cancer. J Clin Endocrinol Metab 2022;107(3):776–87. DOI:10.1210/clinem/dgab731; Tahara M., Brose M.S., Wirth L.J. et al. Impact of dose interruption on the efficacy of lenvatinib in a phase 3 study in patients with radioiodine-refractory differentiated thyroid cancer. Eur J Cancer 2019;106:61–8. DOI:10.1016/j.ejca.2018.10.002; https://ogsh.abvpress.ru/jour/article/view/986

  5. 5
    Academic Journal

    المساهمون: The work was performed without external funding, Работа выполнена без спонсорской поддержки

    المصدر: Head and Neck Tumors (HNT); Том 14, № 2 (2024); 20-26 ; Опухоли головы и шеи; Том 14, № 2 (2024); 20-26 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2024-14-2

    وصف الملف: application/pdf

    Relation: https://ogsh.abvpress.ru/jour/article/view/977/626; Метастазы злокачественных опухолей без выявленного первичного очага. Клинические рекомендации. Ассоциация онкологов России. M., 2017. 24 с.; Состояние онкологической помощи населению России в 2019 году. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2020. 239 с.; Al-Lami A., Gao C., Saddiq M. et al. Reducing the unknowns: a systematic review & meta-analysis of the effectiveness of trans-oral surgical techniques in identifying head and neck primary cancer in carcinoma unknown primary. Oral Oncol 2022;126:105748. DOI:10.1016/j.oraloncology.2022.105748; Рудык А.Н., Зинченко С.В., Хасанов Р.Ш. И др. Результаты диагностики и лечения больных с метастазами плоскоклеточного рака в лимфатические узлы шеи без выявленного первичного очага. Сибирский онкологический журнал 2010;37(1):64–7.; Саприна О.А. Диагностика и лечение больных с метастазами плоскоклеточного рака в лимфатические узлы шеи без выявленного первичного очага. Российский онкологический журнал 2014;3:52–6.; Cheol Park G., Roh J.L., Cho K.J. et al. 18F-FDG PET/CT vs human papillomavirus, p16 and Epstein–Barr virus detection in cervical metastatic lymph nodes for identifying primary tumors. Int J Cancer 2017;140(6):1405–12. DOI:10.1002/ijc.30550; Зинченко С.В., Хасанов Р.Ш., Рудык А.Н. лечение больных с метастазами злокачественных опухолей без выявленного первичного очага. Вестник РОНЦ им. Н.Н. Блохина РАМН 2009;20(3):3–11.; Yasui T., Morii E., Yamamoto Y. et al. Human papillomavirus and cystic node metastasis in oropharyngeal cancer and cancer of unknown primary origin. PLoS One 2014;9(4):e95364. DOI:10.1371/journal.pone.0095364; Davies-Husband C.R. Tongue base mucosectomy for carcinoma of unknown primary using endoscopic electrocautery: rationale for wider implementation of an institutionally restricted technique. J Laryngol Otol 2018;132(12):1138–42. DOI:10.1017/S0022215118002062; Ofo E., Spiers H., Kim D., Duvvuri U. Transoral robotic surgery and the unknown primary. ORL J Otorhinolaryngol Relat Spec 2018;80(3–4):148–55. DOI:10.1159/000490596; Поляков А.П., Панасейкин Ю.А. Метастазы в лимфоузлы шеи без первично выявленного очага. Голова и шея 2014;4:35–8.; Wagner S., Langer C., Wuerdemann N. et al. Predictors for survival of patients with squamous cell carcinoma of unknown primary in the head and neck region. Cancers 2023;15(7):2167. DOI:10.3390/cancers15072167; Farooq S., Khandavilli S., Dretzke J. et al. Transoral tongue base mucosectomy for the identification of the primary site in the workup of cancers of unknown origin: systematic review and metaanalysis. Oral Oncol 2019;91:97–106. DOI:10.1016/j.oraloncology.2019.02.018; https://ogsh.abvpress.ru/jour/article/view/977

  6. 6
    Academic Journal
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
    Academic Journal
  12. 12
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Academic Journal